Literature DB >> 25311170

Lipid signaling in adipose tissue: Connecting inflammation & metabolism.

Mojgan Masoodi1, Ondrej Kuda2, Martin Rossmeisl2, Pavel Flachs2, Jan Kopecky3.   

Abstract

Obesity-associated low-grade inflammation of white adipose tissue (WAT) contributes to development of insulin resistance and other disorders. Accumulation of immune cells, especially macrophages, and macrophage polarization from M2 to M1 state, affect intrinsic WAT signaling, namely anti-inflammatory and proinflammatory cytokines, fatty acids (FA), and lipid mediators derived from both n-6 and n-3 long-chain PUFA such as (i) arachidonic acid (AA)-derived eicosanoids and endocannabinoids, and (ii) specialized pro-resolving lipid mediators including resolvins derived from both eicosapentaenoic (EPA) and docosahexaenoic acid (DHA), lipoxins (AA metabolites), protectins and maresins (DHA metabolites). In this respect, potential differences in modulating adipocyte metabolism by various lipid mediators formed by inflammatory M1 macrophages typical of obese state, and non-inflammatory M2 macrophages typical of lean state remain to be established. Studies in mice suggest that (i) transient accumulation of M2 macrophages could be essential for the control of tissue FA levels during activation of lipolysis, (ii) currently unidentified M2 macrophage-borne signaling molecule(s) could inhibit lipolysis and re-esterification of lipolyzed FA back to triacylglycerols (TAG/FA cycle), and (iii) the egress of M2 macrophages from rebuilt WAT and removal of the negative feedback regulation could allow for a full unmasking of metabolic activities of adipocytes. Thus, M2 macrophages could support remodeling of WAT to a tissue containing metabolically flexible adipocytes endowed with a high capacity of both TAG/FA cycling and oxidative phosphorylation. This situation could be exemplified by a combined intervention using mild calorie restriction and dietary supplementation with EPA/DHA, which enhances the formation of "healthy" adipocytes. This article is part of a Special Issue entitled Oxygenated metabolism of PUFA: analysis and biological relevance."
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Calorie restriction; Futile substrate cycle; Healthy adipocyte; Lipid mediator; Macrophage; Omega-3 fatty acids

Mesh:

Substances:

Year:  2014        PMID: 25311170     DOI: 10.1016/j.bbalip.2014.09.023

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  69 in total

Review 1.  Modulation of innate immunity of patients with Alzheimer's disease by omega-3 fatty acids.

Authors:  Milan Fiala; Gijs Kooij; Karen Wagner; Bruce Hammock; Matteo Pellegrini
Journal:  FASEB J       Date:  2017-04-18       Impact factor: 5.191

2.  The PGE2 EP3 Receptor Regulates Diet-Induced Adiposity in Male Mice.

Authors:  Ryan P Ceddia; DaeKee Lee; Matthew F Maulis; Bethany A Carboneau; David W Threadgill; Greg Poffenberger; Ginger Milne; Kelli L Boyd; Alvin C Powers; Owen P McGuinness; Maureen Gannon; Richard M Breyer
Journal:  Endocrinology       Date:  2015-10-20       Impact factor: 4.736

3.  Duodenojejunal Bypass Plus Sleeve Gastrectomy Reduces Infiltration of Macrophages and Secretion of TNF-α in the Visceral White Adipose Tissue of Goto-Kakizaki Rats.

Authors:  Hao Yu; Zhigao Song; Hongbin Zhang; Kehong Zheng; Junfang Zhan; Qing Luo; Jingbo Sun; Li Liang; Xiaojiang Dai; Liangping Wu
Journal:  Obes Surg       Date:  2019-06       Impact factor: 4.129

Review 4.  Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer.

Authors:  Guido Eibl; Zobeida Cruz-Monserrate; Murray Korc; Maxim S Petrov; Mark O Goodarzi; William E Fisher; Aida Habtezion; Aurelia Lugea; Stephen J Pandol; Phil A Hart; Dana K Andersen
Journal:  J Acad Nutr Diet       Date:  2017-09-12       Impact factor: 4.910

5.  Reduction of serum FABP4 level by sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes mellitus.

Authors:  Masato Furuhashi; Shinya Hiramitsu; Tomohiro Mita; Takahiro Fuseya; Shutaro Ishimura; Akina Omori; Megumi Matsumoto; Yuki Watanabe; Kyoko Hoshina; Marenao Tanaka; Norihito Moniwa; Hideaki Yoshida; Junnichi Ishii; Tetsuji Miura
Journal:  J Lipid Res       Date:  2015-10-14       Impact factor: 5.922

6.  [Beneficial effect of periodontal therapy on insulin resistance and lipid metabolism in obese rats with periodontitis].

Authors:  Qiao-Xue Chai; Su-Lan Zhong; Jia Ni; Lei Chen; Lei Zhou; Jin-Cai Zhang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-05-20

7.  Lipokine 5-PAHSA Is Regulated by Adipose Triglyceride Lipase and Primes Adipocytes for De Novo Lipogenesis in Mice.

Authors:  Veronika Paluchova; Marina Oseeva; Marie Brezinova; Tomas Cajka; Kristina Bardova; Katerina Adamcova; Petr Zacek; Kristyna Brejchova; Laurence Balas; Hana Chodounska; Eva Kudova; Renate Schreiber; Rudolf Zechner; Thierry Durand; Martin Rossmeisl; Nada A Abumrad; Jan Kopecky; Ondrej Kuda
Journal:  Diabetes       Date:  2019-12-05       Impact factor: 9.461

Review 8.  Adipocyte CD1d determines adipose inflammation and insulin resistance in obesity.

Authors:  Jin Young Huh; Yoon Jeong Park; Jae Bum Kim
Journal:  Adipocyte       Date:  2018-03-06       Impact factor: 4.534

9.  Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease.

Authors:  Emma Börgeson; Andrew M F Johnson; Yun Sok Lee; Andreas Till; Gulam Hussain Syed; Syed Tasadaque Ali-Shah; Patrick J Guiry; Jesmond Dalli; Romain A Colas; Charles N Serhan; Kumar Sharma; Catherine Godson
Journal:  Cell Metab       Date:  2015-06-04       Impact factor: 27.287

10.  Exploring the Process of Energy Generation in Pathophysiology by Targeted Metabolomics: Performance of a Simple and Quantitative Method.

Authors:  Marta Riera-Borrull; Esther Rodríguez-Gallego; Anna Hernández-Aguilera; Fedra Luciano; Rosa Ras; Elisabet Cuyàs; Jordi Camps; Antonio Segura-Carretero; Javier A Menendez; Jorge Joven; Salvador Fernández-Arroyo
Journal:  J Am Soc Mass Spectrom       Date:  2015-09-17       Impact factor: 3.109

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.